Hydralazine and the Treatment of Primary Pulmonary Hypertension
- 3 June 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 306 (22) , 1357-1359
- https://doi.org/10.1056/nejm198206033062210
Abstract
This issue of the Journal contains a report by Packer et al. showing that hydralazine, a widely used systemic arterial vasodilator, did not produce consistent hemodynamic or clinical improvement in patients with primary or secondary pulmonary hypertension.1 This report is not in agreement with the results of a recent study by Rubin and Peter showing that hydralazine was effective in reducing pulmonary vascular resistance and relieving symptoms in four patients with primary pulmonary hypertension.2 The disparate observations on the response to hydralazine in the studies of Packer et al. and of Rubin and Peter deserve further examination and comment. The . . .Keywords
This publication has 10 references indexed in Scilit:
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- Pulmonary vasoconstrictor responses to graded decreases in precapillary blood PO2 in intact-chest catJournal of Applied Physiology, 1981
- Pulmonary vasodilator responses to catecholamines and sympathetic nerve stimulation in the cat. Evidence that vascular beta-2 adrenoreceptors are innervated.Circulation Research, 1981
- Pulmonary Vasodilator Responses to Nitroprusside and Nitroglycerin in the DogJournal of Clinical Investigation, 1981
- Influence of Prostaglandin Synthesis Inhibitors on Pulmonary Vasodilatory Effects of Hydralazine in Dogs with Hypoxic Pulmonary VasoconstrictionJournal of Clinical Investigation, 1981
- Oral Hydralazine Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1980
- Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.Circulation Research, 1979
- Effects of large increases in pulmonary blood flow on pulmonary venous pressure.Journal of Applied Physiology, 1969